A novel therapeutic vaccine targeting the soluble TNFα receptor II to limit the progression of cardiovascular disease: AtheroVax™
Article in Frontiers in Cardiovascular Medicine (July 2023)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Article in Frontiers in Cardiovascular Medicine (July 2023)
Article in Infection and Immunity (June 2023)
Article in Journal of Clinical Medicine of Kazakhstan (January 2023)